Related Experiment Video
Updated: Jun 23, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Olorofim demonstrates in vitro activity against Coccidioides species, including isolates against which fluconazole
Nathan P Wiederhold1,2, Hoja P Patterson1, Dora Ferrer1
1Fungus Testing Laboratory, Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Abstract:
We evaluated the in vitro activity of olorofim against Coccidioides species. Olorofim demonstrated potent in vitro activity against all isolates tested with a minimum inhibitory concentration (MIC) range ≤0.008-0.06 µg/mL and geometric mean MIC of 0.010 µg/mL. This activity was also maintained against isolates with elevated fluconazole MICs (≥16 µg/mL), including strains with MICs ≥32 µg/mL (olorofim MIC range ≤0.008-0.06 µg/mL and geometric mean MICs of ≤0.009 and ≤0.013 µg/mL, respectively).
Insights
Olorofim shows strong in vitro antifungal activity against Coccidioides species. This potent activity was effective even against fungal isolates resistant to fluconazole.
Area of Science:
- Mycology
- Antifungal Research
- Infectious Diseases
Background:
- Coccidioides species are pathogenic fungi causing coccidioidomycosis.
- Antifungal resistance is a growing concern in treating fungal infections.
- Limited treatment options exist for severe or refractory coccidioidomycosis.
Purpose of the Study:
- To evaluate the in vitro antifungal activity of olorofim against various Coccidioides species.
- To determine the minimum inhibitory concentrations (MICs) of olorofim.
- To assess olorofim's efficacy against fluconazole-resistant Coccidioides isolates.
Main Methods:
- In vitro susceptibility testing was performed on Coccidioides isolates.
- Minimum Inhibitory Concentrations (MICs) were determined for olorofim.
- Isolates with known elevated fluconazole MICs were specifically included.
Main Results:
- Olorofim exhibited potent in vitro activity against all tested Coccidioides isolates.
- The geometric mean MIC for olorofim was as low as 0.010 µg/mL.
- Olorofim maintained potent activity against isolates with high-level fluconazole resistance (MICs ≥16 µg/mL and ≥32 µg/mL).
Conclusions:
- Olorofim demonstrates significant in vitro potency against Coccidioides species.
- Olorofim is a promising candidate for treating coccidioidomycosis, including fluconazole-resistant cases.
- Further clinical investigation of olorofim for coccidioidomycosis is warranted.
Related Concept Videos
Antimicrobial Effectiveness
Clinical Significance of Antibiotic Resistance

